Skip to main content

PALISADE CAPITAL MANAGEMENT, LP

Position in RGEN — Repligen Corp

CIK 1009006 FORT LEE, NJ

Position in RGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,976,745
-$13,372,985 QoQ
Shares Held
109,768
-54.4% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#91
of 480 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in RGEN Over Time

Shares Held

Position Value (USD)

Position in Medical Instruments & Supplies

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $55,505,739 across 7 Medical Instruments & Supplies names. RGEN ranks #1 (27.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RGEN
Repligen Corp
This page
109,768 $14,976,745

All Filings in RGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,976,745 109,768
2026-03-31 $28,349,730 240,619
2025-12-31 $38,047,636 232,196
2025-09-30 $34,994,538 261,798
2025-06-30 $32,984,083 265,188
2025-03-31 $34,799,758 273,497
2024-12-31 $37,440,089 260,109
2024-09-30 $36,528,613 245,455
2024-06-30 $30,741,621 243,865
2024-03-31 $33,973,150 184,717
2023-12-31 $41,111,270 228,650
2023-09-30 $39,654,390 249,383
2023-06-30 $34,699,572 245,296
2023-03-31 $39,619,148 235,324
2022-12-31 $38,957,215 230,094
2022-09-30 $43,933,240 234,799
2022-06-30 $38,112,356 234,682
2022-03-31 $43,495,812 231,250
2021-12-31 $65,751,297 248,268
2021-09-30 $84,558,474 292,600
2021-06-30 $57,436,063 287,727
2021-03-31 $57,101,133 293,715
2020-12-31 $54,177,250 282,718
2020-09-30 $50,340,205 341,197
2020-06-30 $40,534,932 327,926
2020-03-31 $31,543,383 326,739